miR-4634 augments the anti-tumor effects of RAD001 and associates well with clinical prognosis of non-small cell lung cancer

Correction: Expression of death receptor 4 is positively regulated by MEK/ERK/AP-1 signaling and suppressed upon MEK inhibition.

(2020) Weilong Yao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT

(2019) Xina Zhang et al.   Molecular Cancer

mTORC1 inhibitor RAD001 (everolimus) enhances non-small cell lung cancer cell radiosensitivity in vitro via suppressing epithelial–mesenchymal transition

(2019) Yu Chen et al.   ACTA PHARMACOLOGICA SINICA

Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

(2019) Rui-Mei Feng et al.   Cancer Communications

Electrochemiluminescence-Microscopy for microRNA Imaging in Single Cancer Cell Combined with Chemotherapy-Photothermal Therapy

(2019) Huairong Zhang et al.   ANALYTICAL CHEMISTRY

Circulating microRNA‐590‐5p acts as a liquid biopsy marker in non‐small cell lung cancer

(2019) Akanksha Khandelwal et al.   CANCER SCIENCE

miR-26 suppresses adipocyte progenitor differentiation and fat production by targeting Fbxl19

(2019) Asha Acharya et al.   GENES & DEVELOPMENT

Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models

(2019) Massimo Moro et al.   JOURNAL OF CONTROLLED RELEASE

Regulation of GSK3 cellular location by FRAT modulates mTORC1-dependent cell growth and sensitivity to rapamycin

(2019) Long He et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Elevated expression of G3BP1 associates with YB1 and p‐AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection

(2019) Hongmei Zheng et al.   Cancer Medicine

Expression of DR5 and c‑FLIP proteins as novel prognostic biomarkers for non‑small cell lung cancer patients treated with surgical resection and chemotherapy

(2019) Hongmei Zheng et al.   ONCOLOGY REPORTS

microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer

(2018) Divya Bhagirath et al.   CANCER RESEARCH

Overview upon miR-21 in lung cancer: focus on NSCLC

(2018) Cecilia Bica-Pop et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Long non-coding RNA SNHG15 promotes CDK14 expression via miR-486 to accelerate non-small cell lung cancer cells progression and metastasis

(2018) Bing Jin et al.   JOURNAL OF CELLULAR PHYSIOLOGY

FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy

(2018) Yi Xiao et al.   Molecular Oncology

MiroRNA-188 Acts as Tumor Suppressor in Non-Small-Cell Lung Cancer by Targeting MAP3K3

(2018) Lili Zhao et al.   MOLECULAR PHARMACEUTICS

miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer

(2018) Xiaojie Yu et al.   Cell Death & Disease

SnapShot: Unconventional miRNA Functions

(2018) Mihnea Paul Dragomir et al.   CELL

Endometrial miR-543 Is Downregulated During the Implantation Window in Women With Endometriosis-Related Infertility

(2018) Puyu Yang et al.   Reproductive Sciences

Epidemiology of lung cancer in China

(2018) Maomao Cao et al.   Thoracic Cancer

High expression of heat shock protein 10 correlates negatively with estrogen/progesterone receptor status and predicts poor prognosis in invasive ductal breast carcinoma

(2017) Shuzhou Chu et al.   HUMAN PATHOLOGY

mTOR Kinase Inhibition Effectively Decreases Progression of a Subset of Neuroendocrine Tumors that Progress on Rapalog Therapy and Delays Cardiac Impairment

(2017) Melissa A. Orr-Asman et al.   MOLECULAR CANCER THERAPEUTICS

Novel Hsp90 inhibitor platycodin D disrupts Hsp90/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor

(2017) Ting Li et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Suppression Of β-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma

(2017) Weiyuan Wang et al.   Theranostics

Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies

(2016) Giuseppa Pistritto et al.   Aging-US

The role of microRNAs in resistance to targeted treatments of non-small cell lung cancer

(2016) Hongjing Zang et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Novel combination of serum microRNA for detecting breast cancer in the early stage

(2016) Akihiko Shimomura et al.   CANCER SCIENCE

Relationship between miR-7 expression and treatment outcomes with gefitinib in non-small cell lung cancer

(2016) Kun Mou et al.   Oncology Letters

CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway

(2016) Qiuyuan Wen et al.   Oncotarget

Flot-2 Expression Correlates with EGFR Levels and Poor Prognosis in Surgically Resected Non-Small Cell Lung Cancer

(2015) Qiuyuan Wen et al.   PLoS One

Plasma microRNA expression profiles in Chinese patients with rheumatoid arthritis

(2015) Wenhong Wang et al.   Oncotarget

Predicting effective microRNA target sites in mammalian mRNAs

(2015) Vikram Agarwal et al.   eLife

Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway

(2013) Jiri Polivka et al.   PHARMACOLOGY & THERAPEUTICS

Apoptosis in cancer: from pathogenesis to treatment

(2011) Rebecca SY Wong   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

mTOR Kinase Inhibition Causes Feedback-Dependent Biphasic Regulation of AKT Signaling

(2011) V. S. Rodrik-Outmezguine et al.   Cancer Discovery

Life and death by death receptors

(2009) Maria Eugenia Guicciardi et al.   FASEB JOURNAL